Akso Health Group

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Total Revenue $22.9m $107.3m $61.3m $11.4m $1.8m $6.3m $13.2m $2.4m $14.8m $13.8m
Revenue from Contract with Customer, Including Assessed Tax $82.6m $19.0m $6.3m $13.2m
Cost of Revenue $13.7m $31.4m $7.4m $5.0m $545k $5.4m $11.9m $2.3m $8.8m $7.8m
Reconciled Cost Of Revenue $11.9m $2.3m $15.1m $13.8m
Gross Profit $22.9m $107.3m $53.9m $6.9m $1.8m $916k $1.3m $122k ($282k) ($11k)
Operating Expenses $13.0m $31.4m $10.9m $55.0m $32.7m $16.9m $15.5m $8.8m $166.0m
Total Operating Expenses $13.0m $31.4m $10.9m $55.0m $32.7m $16.9m $15.5m $8.8m $166.0m
Operating Income (Loss) $9.9m $75.9m $5.1m ($68.5m) ($30.9m) ($15.9m) ($14.3m) ($8.6m) ($166.3m) ($4.0m)
Additional Financial Items
Amortization of Intangible Assets $2.1m
Foreign Currency Transaction Gain (Loss), before Tax ($592k) ($26)
Goodwill, Impairment Loss $41.4m
Income (Loss) from Continuing Operations, Per Basic Share ($1) ($0) ($0) ($0) ($0)
Income (Loss) from Continuing Operations, Per Diluted Share ($1) ($0) ($0) ($0) ($0)
Sales and marketing $5.2m $15.2m $32.3m $16.5m $1.1m $241k $7k $168k $0 $0
General and administrative $2.6m $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m $4.0m
LOSS FROM CONTINUING OPERATIONS $9.9m $75.9m $5.1m ($68.5m) ($30.9m) ($15.9m) ($14.3m) ($8.6m) ($166.3m) ($4.0m)
Exchange (loss) gain ($749k) $1.1m ($592k) ($26) $272
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES $10.1m $76.5m $7.4m ($66.9m) ($31.1m) ($16.7m) ($13.1m) ($9.1m) ($166.3m) ($20.7m)
(BENEFIT) PROVISON FOR INCOME TAXES $1.5m $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m) ($2.0m)
NET LOSS FROM CONTINUING OPERATIONS ($4.3m) ($4.1m) ($13.1m) ($9.1m) ($135.5m)
Net loss from discontinued operations, net of income taxes $13.1m ($23.8m) ($6.4m) ($12.7m) $11.8m ($4k)
Loss from disposal of discontinued operations, net of income taxes $3.2m ($396k)
NET LOSS $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.8m) ($1.2m) ($9.5m) ($135.5m) ($18.7m)
Less: net (loss) income attributable to non-controlling interest $29k $1k $112k ($58k) ($492k)
NET LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Foreign currency translation adjustment ($1.1m) $6.0m ($6.1m) ($5.3m) $3.9m $1.5m ($2.2m) ($239k) $312k
COMPREHENSIVE (LOSS) $7.5m $71.5m ($604k) ($76.5m) ($30.9m) ($15.4m) ($3.4m) ($9.8m) ($135.2m)
Less: comprehensive income (loss) attributable to non-controlling interest $133k $17 ($261) $391 ($3k)
COMPREHENSIVE (LOSS) ATTRIBUTABLE TO AKSO’S SHAREHOLDERS $7.5m $71.4m ($604k) ($76.5m) ($30.9m) ($15.4m) ($3.4m) ($9.8m) ($135.2m)
Basic (in Shares) $42.3m $45.0m $48.7m $48.8m $48.8m $59.6m $68.6m $141.5m $855.3m
Diluted (in Shares) $42.3m $47.7m $52.9m $48.8m $48.8m $59.6m $68.6m $141.5m $855.3m
Diluted EPS ($0.06) ($0.21) ($0.48) ($0.03)
Diluted NI Availto Com Stockholders $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Excise Taxes $5k $2k $4k $3k
Gain On Sale Of Security ($749k) $1.1m ($592k) ($26) $272
Impairment Of Capital Assets $0 $0 $162.4m $16.7m
Minority Interests ($112k) $58k $492k $45k
Net Income From Continuing And Discontinued Operation $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Net Income From Continuing Operation Net Minority Interest ($13.2m) ($9.1m) ($135.0m) ($18.7m)
Net Interest Income ($804k) $0 $0
Normalized EBITDA ($15.4m) ($8.0m) $160.6m $15.1m
Normalized Income ($14.1m) ($8.6m) ($2.6m) ($3.6m)
Other Gand A $2.6m $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m $4.0m
Reconciled Depreciation $0 $0 $2.1m $2.4m
Salaries And Wages $392k $0 $0
Selling General And Administration $15.5m $8.8m $3.6m $4.0m
Special Income Charges $0 $0 ($162.4m) ($16.7m)
Tax Effect Of Unusual Items $286k ($148k) ($30.0m) ($1.6m)
Tax Provision $1.5m $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m) ($2.0m)
Tax Rate For Calcs $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $10.1m $76.5m $7.4m ($66.9m) ($31.1m) ($16.7m) ($13.1m) ($9.1m) ($166.3m) ($20.7m)
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax ($6.4m) $11.8m ($4k)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($16.9m) ($13.1m) ($9.1m) ($135.5m) ($18.7m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($31.6m) ($16.8m)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $11.8m ($400k)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent ($3.3m) $11.8m
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic ($1.4m) ($9.1m) ($135.0m) ($18.7m)
Total (loss) gain from discontinued operations ($23.8m) ($3.3m) ($12.7m) $11.8m ($400k) $0 $0
Total Unusual Items $1.1m ($592k) ($162.4m) ($16.7m)
Total Unusual Items Excluding Goodwill $1.1m ($592k) ($162.4m) ($16.7m)
Pre-Tax Income $10.1m $76.5m $7.4m ($66.9m) ($31.1m) ($16.7m) ($13.1m) ($9.1m) ($166.3m) ($20.7m)
Net Income Continuous Operations ($16.9m) ($13.1m) ($9.1m) ($135.5m) ($18.7m)
Net Income Discontinuous Operations ($23.8m) ($3.3m) ($12.7m) $11.8m ($400k) $0 $0
Net Income (Loss) Attributable to Parent $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Net Income (Loss) Available to Common Stockholders, Basic $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.9m) ($1.4m) ($9.5m) ($135.0m) ($18.7m)
Net Income (Loss) Attributable to Noncontrolling Interest $29k $1k $112k ($58k) ($492k)
Net Income Including Noncontrolling Interests $8.6m $65.5m $5.5m ($71.2m) ($34.8m) ($16.8m) ($1.2m) ($9.5m) ($135.5m) ($18.7m)
Earnings Per Share, Basic $0.20 $1.46 $0.11 ($1.46) ($0.71) ($0.28) ($0.02) ($0.07) ($0.16) ($0.03)
Earnings Per Share, Diluted $0.20 $1.37 $0.10 ($1.46) ($0.71) ($0.28) ($0.02) ($0.07) ($0.16)
Weighted Average Number of Shares Outstanding, Basic $42.3m 45.0m 48.7m 48.8m 48.8m 59.6m 68.6m 141.5m 855.3m
Basic Average Shares $22.9m $47.2m $285.1m $722.7m
Diluted Average Shares $22.9m $47.2m $285.1m $722.7m
Weighted Average Number of Shares Outstanding, Diluted $42.3m 47.7m 52.9m 48.8m 48.8m 59.6m 68.6m 141.5m 855.3m
Research and Development Expense $2.8m $1.2m $3.2m $441k $421k
Selling, General and Administrative Expense $3.6m
General and Administrative Expense $2.6m $5.8m $9.9m $26.5m $27.2m $15.0m $15.5m $8.6m $3.6m $4.0m
Other Nonoperating Income (Expense) $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k) ($162.3m) ($16.7m)
Costs and Expenses $56.2m $80.0m $32.7m
Marketing and Advertising Expense $11.9m $28.5m $2.8m $176k $6k $7k $168k
Nonoperating Income (Expense) $34k
Operating Lease, Expense $2.0m $399k $467k $11k
Selling and Marketing Expense $5.2m $15.2m $32.3m $16.5m $1.1m $241k $7k $168k $0 $0
Other expense ($19k) ($23k) ($29k) ($655k) ($265k) ($821k) ($338k) ($114k) ($13k)
Current Income Tax Expense (Benefit) $10.6m $5.6m $684k $483k $131k $18k $25k $3k
Interest Expense $804k $0 $0
Interest Expense Non Operating $804k $0 $0
Net Non Operating Interest Income Expense ($804k) $0 $0
Operating Expense $15.5m $8.8m $3.6m $4.0m
Other Income Expense $661k $2.3m $1.6m ($165k) ($781k) $1.2m ($454k) ($162.3m) ($16.7m)
Other Non Operating Income Expenses $57k $138k $34k ($4k)
Interest Income (Expense), Net $590k
Total Other Income (Expense), net $381k $1.2m ($165k) ($781k) $1.2m ($454k) $34k
Income Tax Expense (Benefit) $1.5m $11.0m $1.9m $4.3m $483k $131k $18k $25k ($30.8m) ($2.0m)
Total Expenses $27.4m $11.1m $18.7m $17.8m